28.1 C
Vientiane
Thursday, September 18, 2025
spot_img
Home Blog Page 32

RiverMeadow Expands Global Reach with Launch in AWS Asia Pacific (Auckland) Region

LOS GATOS, Calif., Sept. 15, 2025 /PRNewswire/ — RiverMeadow Software Inc., a leader in workload mobility automation, is excited to announce the availability of its Workload Mobility Platform in the AWS Asia Pacific (Auckland) Region, marking another key milestone in the company’s continued strategic global expansion alongside AWS’s extensive infrastructure. This expansion supports RiverMeadow’s mission to provide seamless, scalable, and secure migration capabilities to customers worldwide.

RiverMeadow provides integrated, end-to-end Multi-Cloud Migration services and software to dramatically reduce the time, cost and risk associated with moving physical, virtual and cloud-based workloads into and between public, private and hybrid clouds. From Discovery and Assessment through Cloud Migration and Optimization, RiverMeadow accelerates your journey to the cloud, ensuring a successful outcome regardless of scale or complexity.
RiverMeadow provides integrated, end-to-end Multi-Cloud Migration services and software to dramatically reduce the time, cost and risk associated with moving physical, virtual and cloud-based workloads into and between public, private and hybrid clouds. From Discovery and Assessment through Cloud Migration and Optimization, RiverMeadow accelerates your journey to the cloud, ensuring a successful outcome regardless of scale or complexity.

The AWS Asia Pacific (Auckland) Region provides customers with greater flexibility to run workloads and securely store data in New Zealand, while improving application performance with lower latency. This new AWS Region supports enterprises, startups, public and private sector organizations, as well as industries such as financial services, education, healthcare, entertainment, and government, enabling them to serve end users more effectively from AWS data centers located in New Zealand. Importantly, it also allows organizations to retain their data onshore with confidence.

RiverMeadow’s commitment to the Asia Pacific region continues to expand, with tailored support now available in multiple AWS regions including Auckland, Taipei, Osaka, Bangkok, and Kuala Lumpur. This growth underscores RiverMeadow’s dedication to delivering end-to-end workload mobility solutions wherever organizations need to operate.

“The momentum in Asia Pacific, and now New Zealand, is undeniable,” said Jim Jordan, CEO of RiverMeadow“Our platform is uniquely positioned to help customers take full advantage of this new AWS region by delivering automation, speed, and security in their migration journeys.”

Why Migrate to AWS Auckland with RiverMeadow?

  • Rapid Time to Value – Begin migrating workloads in as little as 30 minutes, accelerating ROI from day one.
  • Solution Flexibility – Migrate complex environments across hosted and private platforms with full VM and OS flexibility.
  • Scalability – Enable rapid migrations at scale through a decoupled data transfer architecture.
  • Integrated Automation – Shorten migration timelines with integrated and custom automation.
  • Derisked Migrations – Minimize source impact and accelerate acceptance testing.
  • Cost Reduction – Reduce operational expenses by eliminating technical debt.
  • AWS ISV Funding – Available for customers to achieve zero cost migrations to the new Auckland Region.

Discover the advantages of AWS New Zealand by leveraging RiverMeadow’s trusted Workload Mobility Platform. Whether you’re expanding into Asia Pacific, looking to offset rising costs from Broadcom pricing changes, or transitioning away from current hosting/cloud providers, RiverMeadow is the partner of choice.

About RiverMeadow

RiverMeadow provides multi-cloud and hybrid-cloud workload mobility solutions that automate the migration and modernization of existing workloads to any cloud or virtualized environment. With a proven track record across complex enterprise transformations, RiverMeadow is the trusted partner for organizations navigating modernization at scale.

Media Contact

RiverMeadow Software, Inc.
Email: info@rivermeadow.com

WiMi Lays Out Scalable Quantum Convolutional Neural Network to Enhance Image Classification Accuracy and Efficiency

BEIJING, Sept. 15, 2025 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WiMi) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that they are actively exploring Scalable Quantum Convolutional Neural Networks (SQCNN) technology. Compared to existing quantum neural network models, the scalable quantum convolutional neural network model developed by WiMi demonstrates superior performance, significantly improving classification accuracy.

Traditional quantum neural network models, when handling complex image classification tasks, often suffer from biases in classification results due to incomplete or inaccurate feature extraction. In contrast, the scalable quantum convolutional neural network model, through optimized utilization of qubits and a unique network architecture design, can more accurately extract key features from images, thereby significantly improving classification accuracy. Additionally, in terms of model generalization, the scalable quantum convolutional neural network model can better adapt to the characteristics of different datasets, enabling accurate classification even when faced with new data. This advantage makes it more stable and reliable in practical applications, preventing significant performance degradation due to minor data variations. In terms of training efficiency, the scalable quantum convolutional neural network model greatly reduces the time required for training through optimization of quantum algorithms. By leveraging advanced algorithms and efficient quantum computing architectures, the scalable quantum convolutional neural network model significantly enhances application efficiency.

In traditional convolutional neural networks, the convolutional layer performs convolution operations on the image through a sliding convolution kernel to extract local features of the image. In the quantum circuit of the scalable quantum convolutional neural network, similar functionality is achieved by relying on the superposition and entanglement properties of quantum gates. The superposition of quantum gates allows qubits to exist in multiple states simultaneously, which is equivalent to processing multiple features at the same time, significantly improving processing efficiency. The entanglement between qubits establishes more complex correlations, enabling the quantum circuit to learn subtler and deeper features in the image. This unique design allows the quantum circuit of the scalable quantum convolutional neural network to better learn features, providing a solid foundation for subsequent classification tasks.

In particular, in the scalable quantum convolutional neural network system, multiple independent quantum devices can extract features in parallel, a design that is highly innovative and practical. In traditional machine learning tasks, feature extraction is often performed sequentially, which limits processing speed and efficiency. In contrast, the parallel design in the scalable quantum convolutional neural network system allows different quantum devices to simultaneously extract features from different parts of an image or different types of features, akin to multiple workers operating simultaneously in different areas, significantly accelerating the speed of feature extraction. Moreover, this design allows for the flexible use of quantum devices of varying sizes. When facing machine learning tasks of different scales and complexities, quantum devices of appropriate sizes can be selected and combined based on actual needs. For simple, small-scale tasks, smaller quantum devices can be used to reduce costs and computational complexity; for complex, large-scale tasks, multiple larger-scale quantum devices can be combined to meet the computational demands of the task, thereby enabling larger-scale machine learning tasks.

The scalable quantum convolutional neural network explored by WiMi not only achieves parallelization and multidimensionality in feature extraction but also breaks the conflict between computational resources and task complexity through its ability to dynamically adapt to the scale of quantum devices. This innovation not only significantly enhances the accuracy and efficiency of image classification but also strikes a balance between generalization capability and training costs, providing technical support for high-real-time, high-complexity scenarios such as autonomous driving and medical image analysis. With the continuous development of quantum technology, it will propel artificial intelligence toward a higher-dimensional computational paradigm.

About WiMi Hologram Cloud

WiMi Hologram Cloud, Inc. (NASDAQ:WiMi) is a holographic cloud comprehensive technical solution provider that focuses on professional areas including holographic AR automotive HUD software, 3D holographic pulse LiDAR, head-mounted light field holographic equipment, holographic semiconductor, holographic cloud software, holographic car navigation and others. Its services and holographic AR technologies include holographic AR automotive application, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, interactive holographic communication and other holographic AR technologies.

Safe Harbor Statements

This press release contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Among other things, the business outlook and quotations from management in this press release and the Company’s strategic and operational plans contain forward−looking statements. The Company may also make written or oral forward−looking statements in its periodic reports to the US Securities and Exchange Commission (“SEC”) on Forms 20−F and 6−K, in its annual report to shareholders, in press releases, and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. Several factors could cause actual results to differ materially from those contained in any forward−looking statement, including but not limited to the following: the Company’s goals and strategies; the Company’s future business development, financial condition, and results of operations; the expected growth of the AR holographic industry; and the Company’s expectations regarding demand for and market acceptance of its products and services.

Further information regarding these and other risks is included in the Company’s annual report on Form 20-F and the current report on Form 6-K and other documents filed with the SEC. All information provided in this press release is as of the date of this press release. The Company does not undertake any obligation to update any forward-looking statement except as required under applicable laws.

Global Times: How rational consumption drives healthy economic growth without contradicting anti-waste efforts

BEIJING, Sept. 15, 2025 /PRNewswire/ — A netizen from people.cn asked that many interest subsidy “red envelopes ” and e-commerce platform subsidies have been introduced recently, and I’ve even traded in my old phones and housing appliances for new ones. 

“However, some people around me wonder whether boosting consumption will encourage waste. Is it possible to both combat waste and boost consumption?” the netizen asked.

The concern is understandable. Irrational consumption does create waste: Banquets that leave tables full of leftovers, impulse purchases that end up unused. These not only burn resources but also run counter to the very purpose of boosting consumption.

So, what kind of “consumption” should be promoted?

For individuals, sound consumption satisfies both material needs and emotional needs. Buying a new phone can improve communication efficiency and quality of life; taking a trip can refresh one’s mind and broaden one’s horizons. These consumer behaviors, driven by real needs, not only have tangible “functional value” but also provide valuable “emotional value,” satisfying consumers’ yearning for a better life.

From a macro perspective, consumption is a key engine driving economic growth. 

According to the National Bureau of Statistics, China’s total retail sales of consumer goods reached 24.55 trillion yuan ($3.39 trillion) in the first half of the year, up 5.0 percent year-on-year – a 1.5 percentage point acceleration compared to 2024. 

During the same period, official data showed that final consumption expenditure contributed 52 percent to GDP growth, a 7.5 percentage point increase from the previous year, further solidifying consumption’s role as a main driver of economic growth. 

Given the current complex and volatile international landscape, relying more on domestic demand, especially consumption, to drive economic growth will help withstand external headwinds with internal certainty. From this perspective, boosting consumption is not only necessary but also inevitable.

To come to the netizen’s concerns, what we want, however, is not reckless volume-chasing but healthy, sustainable dynamic consumption – It focuses on quality and value, and is completely opposite to waste.

There are also concerns online that campaigns to reduce waste will curb consumption. Is that really the case? Not at all. Campaigning against waste doesn’t mean “not consuming” or “consuming less.” Rather, it means making every expenditure more rational and meaningful.

From smaller portions and on-demand meal preparation that make dining more refined and healthier, to shared bikes and shared offices that significantly improve resource efficiency; from unused items being traded to promote recycling, to new energy vehicles and energy-saving appliances entering millions of households: These changes show that curbing waste does not suppress consumption; it upgrades consumption patterns and structures, and nurtures new growth drivers. The pursuit of greener and low-carbon development is becoming a new trend, injecting new momentum into high-quality economic development.

Curbing waste is a rational and sustainable mind-set that echoes the tradition of hard work and thrift of the Communist Party of China (CPC).

As early as the revolutionary war era, the CPC called for saving every penny for the war effort and the revolutionary cause.

Since the 18th National Congress of the CPC in 2012, President Xi Jinping has attached great importance to food security and repeatedly called for promoting the social custom of practicing thrift and opposing waste. Xi, also general secretary of the CPC Central Committee and chairman of the Central Military Commission, has emphasized on many occasions the need to stop food waste.

The newly revised Regulations on Practicing Thrift and Opposing Waste in Party and Government Organs are the latest effort by China’s top leadership to rein in official perks and promote restraint. The aim is to tighten frugal code for officials and guide society to build consensus and foster a strong atmosphere in which waste is shameful and thrift is honorable.

The way to enrich a country is to save money and benefit the people. The fundamental purpose of Party and government organs leading a frugal life is to ensure that the people live a good life.

This means both “saving where necessary,” unwaveringly curbing extravagance and waste, strictly controlling waste, and reducing unnecessary expenditures; and “spending where necessary.” It also means spending money where it counts, directing more resources to key areas of development and the urgent needs of people’s livelihoods. Both are aligned with the people-centered development philosophy and practice.

“Living well” and “living a good life” are never simply a single choice. We can leverage policy dividends to improve our quality of life through consumption, but we also need to uphold the principle of opposing waste, spending rationally, and conserving resources. This is the perfect compromise between combating waste and boosting consumption.

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

TAIPEI, Sept. 15, 2025 /PRNewswire/ — Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core probiotic strain CP-9 (Bifidobacterium lactis CCTCC M 2014588) has been approved with Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA).

With this notification, Glac Biotech becomes the only probiotic raw material manufacturer in Taiwan to hold multiple FDA GRAS approval, following the recognition of Lactobacillus rhamnosus MP108 in 2023.

Glac Biotech has now secured FDA GRAS approval for two probiotics for use in a broad array of food and beverage products.
Glac Biotech has now secured FDA GRAS approval for two probiotics for use in a broad array of food and beverage products.

Approval Highlights CP-9’s Safety and Quality

According to the FDA filing, CP-9 is authorized for use at levels up to 10⁹ colony-forming units (CFUs) per-serving in a wide range of food and beverage products:

  • Sports and energy drinks
  • Fortified waters
  • Bottled teas
  • Cereals
  • Dairy and non-dairy items
  • Nutrition bars
  • Candies
  • Fruit juices
  • Soy and plant-based protein products
  • Infant foods

The newly approved CP-9 was a finalist at the 2023 NutraIngredients Awards and has been studied for its role in gut health and immune regulation. With FDA GRAS status, CP-9 expands Glac Biotech’s portfolio and is expected to serve the infant and family nutrition markets alongside established strains such as Bifidobacterium lactis BB-12.

Growing Portfolio of Probiotic and Postbiotic Solutions

Glac Biotech’s first GRAS-notified strain, MP108, was shortlisted for the NutraIngredients Awards in 2021 and approved by the FDA in 2023. It was the first probiotic strain in Asia to be approved for infant use. Supported by clinical and safety data, MP108 is permitted for use at up to 10⁹ CFUs per serving in:

  • Sports and energy drinks
  • Fortified waters
  • Nutritional beverages
  • Bottled teas
  • Processed fruits and juices
  • Cereals
  • Cheeses
  • Yogurts
  • Milk-based desserts
  • Soy-based products
  • Nutrition bars
  • Candies
  • Infant foods

Also advancing in postbiotics, Glac’s flagship product Totipro® is available in Europe, Southeast Asia, and North America, and is planned for FDA GRAS submission in the near future. Totipro® is the only raw material publicly declared to meet all four postbiotic categories defined by the International Probiotics Association (IPA): intact cells (IC), cell fragments and cytoplasmic contents (FC), microbial metabolites (MM), and fermentation media containing microbial components (CX).

“FDA GRAS approval represents an important standard of quality and safety. With CP-9 now approved, MP108 already recognized, and Totipro® submission soon, Glac Biotech is advancing its probiotics and postbiotics research with consistency and international alignment. We will continue to base our work on scientific evidence, cooperating with partners worldwide to develop reliable health solutions,” concluded Shin-Yu Tsai, Product and Marketing Department Manager of Glac Biotech.

For more information, visit glacbiotech.com or follow Glac Biotech on LinkedIn and Facebook.

About Glac Biotech

Founded in 2008, Glac Biotech is a subsidiary of Center Laboratories Inc., Taiwan’s largest liquid pharmaceutical manufacturer. The company focuses exclusively on probiotics (PRONULIFE®) and postbiotics (Totipro®), with over 30 researchers and 30 quality specialists overseeing strain development, patents, clinical validation, and international certification.

Ribbon Names Steve McCaffery Executive Vice President, Global Sales

Brings Global Expertise in Accelerating Revenue Growth

PLANO, Texas, Sept. 15, 2025 /PRNewswire/ — Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the appointment of Steve McCaffery as Executive Vice President of Global Sales, effective end of October, 2025. McCaffery will be based in the UK and report to CEO Bruce McClelland.

“As a global company operating in a dynamic marketplace, we continue to evolve our organization to ensure we have the strongest team to meet our customers’ evolving demands and to capitalize on emerging trends,” said Bruce McClelland, CEO of Ribbon. “Steve’s extensive relationships and experience leading through significant technological shifts, including the recent surge in data center investment to support wide-spread adoption of AI, will be a tremendous asset as we drive sustainable growth worldwide. I’m thrilled to welcome him back to Ribbon and look forward to his impactful leadership.”

McCaffery will leverage his considerable experience with Service Providers, Enterprise, Government, and Critical Infrastructure operators across many regions of the world in this new role. He brings a strong track record of helping customers navigate emerging technologies, including the opportunity-rich data center space. McCaffery has held senior roles at major corporations including Halo Technology (an Amphenol company), Motorola, Google, ARRIS and others. He previously served as head of APAC and EMEA sales at Ribbon from 2021 to 2023.

“This is an exciting and evolving time for our industry,” McCaffery said. “I look forward to working with Ribbon’s world-class sales organization and leadership team to deliver exceptional value to our customers, and seize growth opportunities worldwide.”

McCaffery succeeds Dan Redington, who will be leaving Ribbon at the end of the month to pursue other opportunities.

About Ribbon
Ribbon Communications (Nasdaq: RBBN) delivers secure cloud communications and IP and optical networking solutions to service providers, enterprises and critical infrastructure sectors globally. We engage deeply with our customers, helping them modernize their networks for improved competitive positioning and business outcomes in today’s smart, always-on and data-hungry world. Our end-to-end portfolio of communications software and IP Optical networking solutions delivers superior value and innovation by leveraging cloud-native architectures, automation and analytics tools, and leading-edge security. We maintain a keen focus on our commitments to Environmental, Social, and Governance (ESG) matters, offering an annual Sustainability Report to our stakeholders. To learn more about Ribbon, please visit rbbn.com

Important Information Regarding Forward-Looking Statements
The information in this release contains forward-looking statements regarding future events that involve risks and uncertainties. All statements other than statements of historical facts contained in this release, including those regarding the expected benefits from use of Ribbon Communication’s products, are forward-looking statements. The actual results of Ribbon Communications may differ materially from those contemplated by the forward-looking statements. For further information regarding risks and uncertainties associated with Ribbon Communications’ business, please refer to the “Risk Factors” section of Ribbon Communications’ most recent annual or quarterly report filed with the SEC. Any forward-looking statements represent Ribbon Communications’ views only as of the date on which such statement is made and should not be relied upon as representing Ribbon Communications’ views as of any subsequent date. While Ribbon Communications may elect to update forward-looking statements at some point, Ribbon Communications specifically disclaims any obligation to do so.

Investor Contact 
+1 (978) 614-8050
ir@rbbn.com

Media Contact
Catherine Berthier
+1 (646) 741-1974
cberthier@rbbn.com 

NYSE Content Advisory: Pre-Market Update + S&P comes off best week since August

NEW YORK, Sept. 15, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-Market Update + S&P comes off best week since August

Ashley Mastronardi delivers the pre-market update on September 15th

  • Equities are higher Monday morning after a winning week on Wall Street. The S&P 500 recorded its best week since Early August with a gain of 1.6%. The DOW also snapped a losing streak.
  • Investors will be monitoring the latest with Nvidia after China says the firm violated an anti-monopoly law. This week’s activity will be dominated by the Federal Reserve with the central bank to deliver its next policy decision.
  • The Fed’s decision on interest rates will draw headlines, but investors will be keeping a close eye on other data points as well. The Empire State Manufacturing Index was released ahead of todays open.

Opening Bell
Deutsche Bank (NYSE: DB) celebrates Hispanic Heritage Month

Closing Bell
Union Pacific (NYSE: UNP) celebrates the company’s 155th anniversary of listing

Click here to download the NYSE TV App

 

Video – https://mma.prnasia.com/media2/2772918/NYSE_Market_Update_Sept_15.mp4

 

 

 

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor

  • BGE-102, an orally available, brain-penetrant NLRP3 inhibitor, was developed from a hit compound identified using HitGen’s industry-leading DEL technology platform, highlighting the value of DEL to accelerate innovative drug development.
  • The initiation of the BGE-102 Phase 1 clinical study triggers a milestone payment to HitGen.

CHENGDU, China, Sept. 15, 2025 /PRNewswire/ — Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”, SSE: 688222.SH), congratulates its partner BioAge Labs, Inc. (“BioAge”, NASDAQ: BIOA), a clinical-stage biotechnology company based in Emeryville, CA, USA, on the initiation of a Phase 1 clinical study of BGE-102, a novel, potent NLRP3 inhibitor developed from a hit compound identified using HitGen’s industry-leading DEL technology platform. The event triggers an undisclosed milestone payment to HitGen under the collaboration agreement between the two companies.

BGE-102 is a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration being developed initially for the treatment of obesity. NLRP3 is a key driver of age-related inflammation that has been implicated in a broad range of diseases, including neurodegenerative conditions and cardiovascular disease as well as metabolic disorders such as obesity. BioAge identified NLRP3 as a therapeutic target for metabolic and age-related diseases and sought to develop novel inhibitors, leading to the successful collaboration with HitGen.

BGE-102 was developed by BioAge from hit compounds identified in a screen using HitGen’s DEL libraries under a collaboration agreement between the parties. In April 2021, the companies announced the successful identification of promising hit molecules. In February 2024, the companies further detailed their research collaboration outcome in a joint publication in Bioorganic & Medicinal Chemistry Letters, entitled “The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening”. The collaboration has also resulted in joint patent filings covering the structurally novel compounds discovered through the DEL screening process. BioAge and HitGen continue to collaborate on additional drug lead discovery programs for other novel targets using HitGen’s DEL platform.

Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen Inc., stated: “We extend our congratulations to the BioAge team on this exciting progress. The advancement of BGE-102 into clinical studies not only validates the power of HitGen’s DEL platform to discover novel small molecules against challenging targets, but also reinforces the value of our partnership model. We look forward to continuing our collaboration and following the development of this promising candidate.”

“We’re excited to reach this important clinical milestone with BGE-102,” said Kristen Fortney, PhD, CEO and co-founder of BioAge. “HitGen’s DEL platform helped us identify structurally distinct NLRP3 inhibitors with a novel binding site and strong potency and brain penetration. Our collaboration demonstrates the value of combining HitGen’s cutting-edge screening technology with insights from human aging biology to advance potentially transformative treatments for metabolic diseases.”

HitGen is a world leader in the development of DEL technology and applications to early-stage small molecule drug discovery. Its platform includes over 1.2 trillion small molecules generated by the DEL technology, and the efficiency of the screening process has made it possible for HitGen to enable drug discovery projects for many organizations around the world.

About HitGen Inc.

HitGen Inc. (SSE: 688222.SH), is a drug discovery research company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. HitGen has established leading technology platforms to enable the discovery and optimization of small molecules and nucleic acid-based drugs. Our key technology platforms include world-leading DNA-encoded library technology (DEL), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), as well as the emerging technology platforms for oligonucleotide-based therapeutics (OBT), and targeted protein degradation technology (TPD). Meanwhile, we are developing a DEL+AI+Automated DMTA (Design-Make-Test-Analyze) molecular optimization platform to accelerate the discovery and optimization process of preclinical candidate compounds. Through our diverse and flexible business models, we have built up collaboration partnerships with several hundred biopharmaceutical research organizations worldwide. HitGen has multiple programmes from early discovery to clinical trial stage.

About BioAge Labs, Inc.

BioAge (NASDAQ: BIOA) is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The Company’s lead product candidate, BGE-102, is a potent, orally available, brain-penetrant small-molecule NLRP3 inhibitor being developed for obesity. BGE-102 has demonstrated significant weight loss in preclinical models both as monotherapy and in combination with GLP-1 receptor agonists. A Phase 1 SAD/MAD trial of BGE-102 is underway, with initial SAD data anticipated by end of year. The Company is also developing long-acting injectable and oral small molecule APJ agonists for obesity. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging.

AMPLIFON: -42% DIRECT EMISSIONS AND -25% INDIRECT GREENHOUSE GAS EMISSIONS BY 2030

MILAN, Sept. 15, 2025 /PRNewswire/ — Amplifon, a global leader in hearing solutions and services, is launching its climate strategy validated by the Science Based Targets Initiative (SBTi) to reduce greenhouse gas emissions and contribute to achieving the goals of the 2015 Paris Agreement to counteract climate change.

The strategy, Listening to our Planet,” specifically calls for a 42% reduction in the company’s direct greenhouse gas emissions (Scope 1 and 2) by 2030 compared to 2023. Over the same period, the company has committed to reducing indirect Scope 3 emissions by 25%, deriving from purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, employee commuting, upstream leased assets, use of sold products and franchises. The plan also stipulates that, by 2030, 44.36% of its suppliers in terms of emissions related to purchased goods and services will have greenhouse gas emission reduction targets based on climate science.

The launch of a scientifically validated climate strategy,” comments Amplifon CEO Enrico Vita, “represents a further step forward in the process of fully integrating ESG factors into our business. Making concrete commitments to reduce our direct and indirect emissions in the medium term is in line with the sustainability plan we launched last year with 20 concrete and measurable targets for 2026, 2028, and 2030 in the areas of products and services, ethics and environmental responsibility, people, and communities. We want to continue to grow in an increasingly responsible and sustainable manner.”

The Science Based Targets Initiative, a non-profit organization launched in 2015 by a coalition of international actors such as CDP, UN Global Compact, World Resources Institute, WWF, and We Mean Business Coalition, supports companies in setting greenhouse gas emission reduction targets consistent with the latest scientific evidence on climate change.

Amplifon’s Corporate Website 

Amplifon’s Sustainability Plan

New Climate Strategy

Amplifon

Amplifon, hearing care global leader, empowers people to rediscover all the emotions of sound. Amplifon’s over 20,000 people worldwide strive every day to understand the unique needs of every customer, delivering exclusive, innovative and highly personalized products and services, to ensure everyone the very best solution and outstanding experience. The Group, with annual revenues of over 2.4 billion euros, operates through a network of over 10,000 points of sale in 26 Countries and 5 continents.

 

Corporate Communication

Salvatore Ricco

M. 39 335 770 9861

salvatore.ricco@amplifon.com